ArticlePloS one2012

Interleukin-15-induced CD56(+) myeloid dendritic cells combine potent tumor antigen presentation with direct tumoricidal potential.

Sébastien Anguille et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.